AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.18
−2.77%Forward multiples
Based on analyst estimates
- P/E forward
- 7.29x
- P/E 2026E
- 7.87x
- P/E 2027E
- 7.35x
- P/E 2028E
- 6.92x
- P/S forward
- 1.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.32x
- PEG TTM
- 0.16x
- Price / book
- 1.28x
- Price / sales
- 1.35x
- Price / cash flow
- 5.34x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 1.90x
- EV / EBITDA
- 7.92x
- EV / EBIT
- 12.11x
- Market cap
- $986.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026